Clinical Trial Update: A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial in early rheumatoid arthritis evaluated starting adalimumab after methotrexate failure. The study results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2016-11-01